Hotline for Health Services for Displaced Lebanese 1787
Hotline for the Patient Admission to Hospitals 01/832700
COVID-19 Vaccine Registration Form covax.moph.gov.lb
MoPH Hotline 1214
Are you a new member? Sign up now
 
Let us help you
Read about the latest topics.

European Union support for the Lebanese Healthcare System reaches €173 million

18 December 2018 - The European Union has renewed its commitment to strengthen the Lebanese health care system and secure access to chronic medications, vaccines and essential medical commodities to the most vulnerable population in Lebanon. Through an additional contribution of 19 million Euro from the EU Regional Trust Fund in response to the Syrian crisis, UNICEF and WHO will be able to support to people in need living in Lebanon by ensuring provision of primary healthcare services and strengthening the health system.
 
The additional funding was announced today during a joint press conference headed by the Minister of Public Health, Ghassan Hasbani, EU Ambassador Christina Lassen, WHO representative Dr. Imane Shankiti, and UNICEF Representative, Tanya Chapuisat. The donation is part of a package of support of 173 million Euro which the European Union has invested in the health sector to strengthen the system and to help meet the basic health needs of both Lebanese citizens and Syrian refugees in a time of great pressure on service delivery and health infrastructure.
 
“We thank the commitment of the European Union and the support of the World Health Organization and UNICEF in strengthening the healthcare system to meet the needs of both Lebanese and Syrian refugees,” said Minister Hasbany.
 
EU Ambassador Lassen highlighted that "the projects we are launching today are part of a 173 million Euro health package that includes primary and secondary healthcare and aims at achieving quality, affordable and accessible health services for everyone in need in Lebanon".
 
“The generous support of the EU to the health system has sealed a long-standing partnership between the MOPH, WHO and UNICEF, and ensured that health services were of good quality, and that outbreaks and health risks are identified and acted upon early enough” said Imane Shankiti, WHO representative. “Reinforcing the health system capacity, along with filling critical health services with EU support ensured that no patient in need for health care was left behind”.
 
“The strong partnership we have with the EU, the ministry of Public Health and WHO has ensured that every child in Lebanon has access to quality vaccines to remain safe from outbreaks of preventable diseases,” said Tanya Chapuisat, UNICEF Representative to Lebanon. “Through EU funding we are able to save lives and strengthen systems to shape a better future for children”.
 
 
    2
ATC Name B/G Ingredients Dosage Form Price
B03BB01 FOLICIL G Folic acid - 5mg 5mg Tablet 584,571 L.L
C01BC04 FLECAINE B Flecainide acetate - 100mg 100mg Tablet, scored 878,873 L.L
C01BC04 FLECAINIDE ARROW LAB G Flecainide acetate - 100mg 100mg Tablet, scored 588,603 L.L
C01BC04 FLECAINIDE BIOGARAN L.P. G Flecainide acetate - 100mg 100mg Capsule, extended release 1,154,361 L.L
C01BC04 FLECAINIDE BIOGARAN L.P. G Flecainide acetate - 50mg 50mg Capsule, extended release 1,154,361 L.L
C03BA11 FLUDEX B Indapamide - 1.5mg 1.5mg Tablet, sustained release 517,379 L.L
C03CA01 FURESIX 40 G Furosemide - 40mg 40mg Tablet 166,381 L.L
C03CA01 FUROSETIC G Furosemide - 40mg 40mg Tablet, scored 121,586 L.L
C03CA01 FRURETIC G Furosemide - 20mg/2ml 20mg/2ml Injectable solution 2,600,655 L.L
C03CA01 FUROLIX G Furosemide - 20mg/2ml 20mg/2ml Injectable solution 1,612,611 L.L
C03CA01 FUROSEMIDE RENAUDIN G Furosemide (sodium) - 20mg/2ml 20mg/2ml Injectable solution 451,531 L.L
C03CA01 FUROSEMIDE SALF G Furosemide - 20mg/2ml 20mg/2ml Injectable solution 216,359 L.L
C03CA01 FUROSEMIDE RENAUDIN G Furosemide - 250mg/25ml 250mg/25ml Injectable solution 1,791,342 L.L
C03CA01 FUROSEMIDE S.A.L.F. G Furosemide - 250mg/25ml 250mg/25ml Injectable solution 919,188 L.L
C10AB05 FENOFIBRATE ARROW G Fenofibrate - 160mg 160mg Tablet 639,669 L.L
C10AB05 FENOSUP LIDOSE G Fenofibrate - 160mg 160mg Capsule 774,053 L.L
C10AB05 FINOFIB BENTA G Fenofibrate - 160mg 160mg Tablet, film coated 788,388 L.L
C10AB05 FINACOR G Fenofibrate micronised - 160mg 160mg Capsule 774,309 L.L
C10AB05 FENOGAL G Fenofibrate micronised - 200mg 200mg Capsule, micronized 392,402 L.L
D04AA13 FENISTIL B Dimethindene maleate - 1mg/g 1mg/g Gel 196,201 L.L
D06AX01 FUCIDIN B Fusidic acid - 20mg/g 2% Cream 259,362 L.L
D06AX01 FUCIDIN CREAM B Fusidic acid - 2% 2% Cream 491,846 L.L
D06AX01 FUCIDIN CREAM B Fusidic acid - 2% 2% Cream 345,368 L.L
D06AX01 FUTASOLE G Fusidic acid - 20mg/g 2% Cream 145,135 L.L
D06AX01 FUCIDIN B Fusidic acid (sodium salt) - 20mg/g 2% Ointment 259,362 L.L
D06AX01 FUCIDIN OINTMENT B Fusidic acid (sodium salt) - 2% 2% Ointment 491,846 L.L
D06AX01 FUCIDIN OINTMENT B Fusidic acid (sodium salt) - 2% 2% Ointment 345,368 L.L
D06AX01 FUCIKALT G Fusidic acid (sodium salt) - 2% 2% Ointment 209,895 L.L
D07AC04 FLUOCINOLONE ACETONIDE G Fluocinolone acetonide - 0.25mg/g 0.25mg/g Cream 296,925 L.L
D07CC01 FUCICORT B Fusidic acid - 20mg/g, Betamethasone (valerate) - 1mg/g Cream 376,276 L.L
    2
Sitemap
© Copyrights reserved to Ministry of Public Health 2025